Protective effect of pyruvate upon cultured mesothelial cells exposed to 2 mM hydrogen peroxide

Nephron

Volumn 84, Issue 4, 2000, Pages 362-366

  Shostak, Avshalom ^a   Gotloib, Lazaro ^a   Kushnier, Raisa ^a   Wajsbrot, Valery ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Biocompatibility; High glucose; Mesothelial cell culture; Oxidative stress; Peritoneal dialysis; Peritoneal dialysis solutions; Pyruvate

Indexed keywords

DIALYSIS FLUID; HYDROGEN PEROXIDE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; MESOTHELIUM CELL; NONHUMAN; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RAT;

EID: 0034027628     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045612     Document Type: Article

References (52)

1. Breborowicz A: Free radicals in peritoneal dialysis: Agents of damage? Perir Dial Int 1992;12: 194-198.
2. Shostak A, Pivnik K, Gotloib L: Cultured rat mesothelial cells generate hydrogen peroxide. A new player in peritoneal defense? J Am Soc Nephrol 1996;7:2371-2378.
3. Witowski J, Weczorowska K, Martis L, Serkes KD, Orcopoulos DG: Toxicity of free radicals to mesothelial cells and peritoneal membrane. Nephron 1993;65:62-66.
4. Gotloib L, Shostak A, Bar-Sella P, Cohen R: Continuous mesothelial injury and regeneration during long-term peritoneal dialysis. Perit Dial Bull 1987;7:148-155.
5. Kashiwagi A, Nishio Y, Asahina T, Ikebuchi M, Harada N, Tanaka Y, Takahara N, Taki H, Ohala T, Midaka M, Saeki Y, Kikkawa R: Pyruvate improves deleterious effect of high glucose and activation of the pentose phosphate pathway and glutathione redox cycle in endothelial cells. Diabetes 1995;44:520-526.
6. Shainkin-Kestenbaum R, Giatt Y, Berlyne GM: The presence and toxicity of guanidino-propionic acid in uremia. Kidney Int 1975;7: 302-305.
7. Rhee MS, McGoldrick MD, Meuwissen HJ: Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism. Nephron 1986;42:6-13.
8. Kuroda M, Asaka S, Tofuku Y, Takeda R: Serum antioxidant activity in uremic patients. Nephron 1985;41:293-298.
9. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJ: Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients: Perit Dial Int 1992;12:252-256.
10. Cheeseman KH, Slater TF: An introduction to free radical biochemistry. Br Med Bull 1993; 29:481-493.
11. Winrow VR, Winyard PG, Morris CJ, Blake DR: Free radicals in inflammation: Second messengers and mediators of tissue destruction. Br Med Bull 1993;49:506-522.
12. Nath KA, Enright H, Nutter L, Fischereder M, Zou JN, Hebel RP: Effect of pyruvate on oxidant injury to isolated and cellular DNA. Kidney Int 1994;45:166-176.
13. Gryzbowski A, Breborowicz A, Martis L, Oreopoulos DH: Antioxidant mechanisms in human peritoneal mesothelial cells. Effect of free radicals and osmotic solutes. Peril Dial Int 1995;15:3-38.
14. Brunkhorst R, Mahiout A: Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained integrity and proliferation of cultured human mesothelial cells. Kidney Int 1995;48: 177-181.
15. Mahiout A, Brunkhorst R: Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 1995;10:391-394.
16. Davender K, Williams JD, Toplcy N: Cell function in pyruvate-buffered peritoneal dialy-sis solutions: Effects on mesothelial cell viability, IL-6 synthesis and mRNA expression (abstract). Perit Dial Int 1996;16:221.
17. Institute of Laboratory Animal Resources: Guide for the Care and Use of Laboratory Animals: DHEW Publ No (NlH) 72-73. Washington. National Institute of Health, 1972.
18. Satoh K, Prescott SM: Culture of mesothelial cells from bovine pericardium and characterization of their arachidonate metabolism. Biochim Biophys Acta 1987;54:35-45.
19. Spragg RG, Hinshaw DB, Hyslop PA, Schrufstatter IU, Cochrame CG: Alterations in adenosine triphosphate and energy charge in cultured endothelial and p388 D cells after oxidant injury. J Clin Invest 1985;76:1471-1476.
20. 2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 1987;325:78-81.
21. Mosman T: Rapid colorimetric assay for cellular growth survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
22. Keisari Y: A colorimetric microtiter assay for the quantilation of cytokine activity on adherent cells in tissue culture. J Immunol Methods 1992;146:155-161.
23. Shopsis G, Eng B: Rapid cytotoxicity testing using a semiautomated protein determination on cultured cells. Toxicol Lett 1985;26:1-8.
24. Glantz SA: Primer of Biostatistics. New York, McGraw-Hill, 1992, pp 334-353.
25. Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
26. Fanton JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;207:397-418.
27. Halliwell B, Cuticridge MC: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
28. Seeger W, Hansen T, Rossig R, Schniehl T, Schutte H, Kramer HJ, Walmrath D, Weissmann N, Grimminger R, Suttorp N: Hydrogen peroxide induced increase in lung endothelial and epithelial permeability: Effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res 1995;50:1-17.
29. Baynes JW: Role of oxidative stress in development of complication of diabetes. Diabetes 1994;40:405-412.
30. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: A mechanism for accelerated arteriosclerosis in diabetes. Biochem Biophys Res Commun 1990;173:932-939.
31. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 1994;37:264-269.
32. 2 in high glucose medium. Diabetes 1995;44:520-526.
33. Gotloib L, Bar-Sella P, Shostak A: Reduplicated basal lamina of small venules and mesothelium of human peritoneum. Peril Dial Bull 1985;5:212-215.
34. Williamson JT, Kilo G: Basement membrane thickening and diabetic microangiopathy. Diabetes 1976;25(suppl 2):925-927.
35. Shostak A, Gotloib L: Increased peritoneal permeability to albumin in streptozotocin diabetic rats. Kidney Int 1996;49:705-714.
36. Amdrac U, Singh J, Ziegler-Shylakakis K: Pyruvate and related u-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. Toxicol Lett 1985;28: 93-98.
37. Cavallini L, Valente M, Rigobello M: The protective action of pyruvate on recovery of ischemic heart: Comparison with other oxidizable substrates. J Mol Cell Cardiol 1990;22:143-154.
38. Salahudeen AK, Clark EC, Nath KA: Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 1991;88:1886-1893.
39. Nath KA, Salahudeen AK: Autoxidation of cysteine generates hydrogen peroxide: Cytotoxicity and attenuation by pyruvate. Am J Physiol 1993;264:F306-F314.
40. Odonnel-Tormey J, Nathan CF, Lanks K, Deboer CJ, De La Harpe J: Secretion of pyruvate: An antioxidant defense of mammalian cells. J Exp Med 1987;165:500-514.
41. Holleman MAF: Notice sur l'action de l'eau oxygénée sur les acides acétoniqucs et sur les dicétones 1, 2. Reel Trav Chim Pay-Bas Belg 1904;23:169-171.
42. Holley AE, Cheeseman KH: Measuring free radical reactions in vivo. Br Med Bull 1993;49: 494-505.
43. 2 release by macrophages. Microb Pathog 1993; 14:169-176.
44. Daniels I, Bhatia KS, Porter CJ, Lindsay MA, Morgan AG, Burden RP, Fletcher J: Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. Clin Diagn Lab Immunol 1996;3:682-688.
45. 2 release by human polymorphonuclear leucocytes. Immunology 1989;67: 120-125.
46. Whorton AR, Montgomery ME, Kent RS: Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells. J Clin Invest 1985;76:295-302.
47. Young DS: Implementation of SI units for clinical laboratory data. Style specifications and conversion tables. Ann Intern Med 1987;106: 114-129.
48. Murer H, Burckhardt G: Membrane transport of anions across epithelia of mammalian small intestine and kidney proximal tubule. Rev Physiol Biochem Pharmacol 1983;96:1-51.
49. Halestrop APR, Scott D, Thomas P: Mitochondrial pyruvate transport and its hormonal regulation. Int J Biochem 1980;11:97-105.
50. Dijkstra U, Gareels F, Joosten E, Wevers R. Lamers K, Doesburg W, Renier W: Friedreich's ataxia: Intravenous pyruvate load to demonstrate a defect in pyruvate metabolism. Neurology 1984;34:1493-1497.
51. Van Erven PMN, Gabreels FJM, Wevers RA, Docsburg WH, Ruitenbeek W, Renier WO, Lamers KJB: Intravenous pyruvate loading test in Leigh's syndrome. J Neurol Sci 1987;77: 217-227.
52. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Acute renal and long-term changes observed in imprints of mouse mesothelium exposed to glucose, enriched, lactated, buffered dialysis solutions. Nephron 1995;70:466-477.